{
    "url": "https://www.aafp.org/pubs/afp/issues/2005/1101/p1917.html#afp20051101p1917-f1",
    "title": "ACOG Guidelines for Treating Prenatal Hemoglobinopathy | AAFP",
    "author": "AMBER HUNTZINGER",
    "doi": "Am Fam Physician.2005;72(9):1917",
    "abstract": null,
    "headers": [],
    "content": [
        {
            "parent": -1,
            "text": "The Committee on Practice Bulletins–Obstetrics of the American College of Obstetricians and Gynecologists (ACOG) has released a practice bulletin on screening for and managing hemoglobinopathies during pregnancy. Practice Bulletin Number 64, “Hemoglobinopathies in Pregnancy,” was published in the July 2005 issue ofObstetrics & Gynecology."
        },
        {
            "parent": -1,
            "text": "The ACOG recommendations, which are based on good, consistent evidence, include the following:"
        },
        {
            "parent": -1,
            "text": "Persons of African, Southeast Asian, and Mediterranean descent are at increased risk of carrying hemoglobinopathies and should be offered screening and genetic counseling.Figure 1is an algorithm for the antepartum evaluation for hematologic assessment of persons from high-risk groups.Appropriate hemoglobinopathy screening should include a complete blood count and hemoglobin electrophoresis. Solubility tests alone should not be used as screening tools.Parents at high risk of having a child with sickle cell disease or thalassemia should be offered genetic counseling, and a prenatal diagnosis should be obtained through DNA analysis of cultured amniocytes or chorionic villi."
        }
    ],
    "locked": true
}